{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:45:19Z","timestamp":1792075519951,"version":"4.4.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study evaluated the efficacy of different high-flow nasal cannula (HFNC) weaning protocols in critically ill adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>This multicenter, randomized controlled trial was conducted from December 1, 2022, to August 31, 2024, based on the suggested protocol (SLOWH trial). Experts reviewed the trial between October 2, 2024, and April 15, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Randomization was performed by a research coordinator using a sequence of random numbers generated by an independent statistician blinded to both researchers and participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Adults (\u2265 18 yr old) in the ICU who met the weaning criteria after receiving HFNC were included. Among 102 patients from three tertiary care hospitals, 15 were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>\n                      The remaining patients were randomized into three intervention groups: flow reduction (FR) first, F\n                      <jats:sc>io<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      reduction (OR) first, or simultaneous reduction (SR). The primary outcome was the HFNC weaning success rate, defined as successful transition to conventional oxygen therapy without the need for HFNC reapplication, noninvasive ventilation, or endotracheal intubation within 24 hours.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      A total of 87 adults completed the trial (FR,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 31 [male, 52%]; OR,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 26 [male, 77%]; SR,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 30 [male, 53%]). The weaning success rates in the FR, OR, and SR groups were 94%, 81%, and 77%, respectively (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.15). The median [interquartile range] weaning duration was 31.0 hours (29.0\u201345.8\u2009hr), 29.5 hours (28.0\u201360.4\u2009hr), and 29.5 hours (26.5\u201345.0\u2009hr) in the FR, OR, and SR groups, respectively, with no statistically significant difference among groups (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.87).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this randomized trial, no statistically significant differences were observed among the three HFNC weaning strategies in terms of weaning success or duration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007379","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:00:29Z","timestamp":1792072829000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Weaning Strategies for High-Flow Nasal Cannula in Critically Ill Adults: A Randomized Clinical Trial"],"prefix":"10.1097","author":[{"given":"Taewoo","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Gun","family":"Kwack","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghoon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyoung","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Jin","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yoon","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"R1-20261015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4187\/respcare.04577","article-title":"High-flow nasal cannula oxygen therapy in adults: Physiological benefits, indication, clinical benefits, and adverse effects.","volume":"61","author":"Nishimura","year":"2016","journal-title":"Respir Care"},{"key":"R2-20261015","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.201605-0916OC","article-title":"Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure.","volume":"195","author":"Mauri","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20261015","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00134-020-06228-7","article-title":"Use of nasal high flow oxygen during acute respiratory failure.","volume":"46","author":"Ricard","year":"2020","journal-title":"Intensive Care Med"},{"key":"R4-20261015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/380686","article-title":"The effects of gas humidification with high-flow nasal cannula on cultured human airway epithelial cells.","volume":"2012","author":"Chidekel","year":"2012","journal-title":"Pulm Med"},{"key":"R5-20261015","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"key":"R6-20261015","doi-asserted-by":"crossref","first-page":"2101574","DOI":"10.1183\/13993003.01574-2021","article-title":"ERS clinical practice guidelines: High-flow nasal cannula in acute respiratory failure.","volume":"59","author":"Oczkowski","year":"2022","journal-title":"Eur Respir J"},{"key":"R7-20261015","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1097\/CCM.0000000000002693","article-title":"Effects of high-flow nasal cannula on the work of breathing in patients recovering from acute respiratory failure.","volume":"45","author":"Delorme","year":"2017","journal-title":"Crit Care Med"},{"key":"R8-20261015","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00134-017-4890-1","article-title":"Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: Effects of increasing flow rates.","volume":"43","author":"Mauri","year":"2017","journal-title":"Intensive Care Med"},{"key":"R9-20261015","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1097\/PCC.0000000000001181","article-title":"A novel weaning protocol for high-flow nasal cannula in the PICU.","volume":"18","author":"Betters","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20261015","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.chest.2025.01.037","article-title":"High-flow nasal cannula liberation: Who, when, and how?","volume":"168","author":"Freeman","year":"2025","journal-title":"Chest"},{"key":"R11-20261015","doi-asserted-by":"crossref","first-page":"00203","DOI":"10.1183\/23120541.00203-2022","article-title":"High-flow nasal cannula oxygen therapy: P-SILI or not P-SILI?","volume":"8","author":"Artaud-Macari","year":"2022","journal-title":"ERJ Open Res"},{"key":"R12-20261015","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1513\/AnnalsATS.201809-627WS","article-title":"Optimizing home oxygen therapy. An official American Thoracic Society Workshop Report.","volume":"15","author":"Jacobs","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"R13-20261015","doi-asserted-by":"crossref","first-page":"e213990","DOI":"10.1001\/jamanetworkopen.2021.3990","article-title":"Mortality and readmission rates among patients with COVID-19 after discharge from acute care setting with supplemental oxygen.","volume":"4","author":"Banerjee","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R14-20261015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13054-025-05254-5","article-title":"Heterogeneity of treatment effect: The case for individualising oxygen therapy in critically ill patients.","volume":"29","author":"Martin","year":"2025","journal-title":"Crit Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:00:32Z","timestamp":1792072832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":14,"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007379","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}